SLC17A6 and Hypoglycemia: Globally interfering with VMN function (e.g., by deleting VMN vGLUT2, thereby blocking glutamatergic signaling by VMN neurons) mediates effects opposite to those of VMN activation, impairing glucagon secretion, glycogenolysis, and hepatic transcriptional responses to hypoglycemia and during fasting26.